Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update

Affiliations

• ¹ Department of Pharmacy Practice & Science, University of Arizona College of Pharmacy, Tucson, Arizona, USA.
• ² Sarver Heart Center, University of Arizona College of Medicine, Tucson, Arizona, USA.
• ³ Department of Medicinal Chemistry, University of Washington School of Pharmacy, Seattle, Washington, USA.
• ⁴ Discipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
• ⁵ Department of Biomedical Data Science, Stanford University, Stanford, California, USA.
• ⁶ Department of Epidemiology, University of Washington, Seattle, Washington, USA.
• ⁷ Institute of Public Health Genetics, University of Washington, Seattle, Washington, USA.
• ⁸ Department of Pharmacy and Intermountain Precision Genomics, Intermountain Healthcare, Salt Lake City, Utah, USA.
• ⁹ Genomic Medicine Institute, Geisinger Health System, Danville, Pennsylvania, USA.
• ¹⁰ INUBE Extremadura University Biosanitary Research Institute and Medical School, Badajoz, Spain.
• ¹¹ Department of Medicine, Stanford University, Stanford, California, USA.
• ¹² Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
• ¹³ Department of Neurology, Thomas Jefferson University Hospital Methodist Hospital Division of Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
• ¹⁴ Division of Clinical Pharmacology, Toxicology & Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA.
• ¹⁵ School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.
• ¹⁶ Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
• ¹⁷ Department of Veteran Affairs and Departments of Medicine and Pharmacology/Toxicology, Indiana University School of Medicine, Indianapolis, Indiana, USA.